Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Choriocarcinoma
ADR ID BADD_A00916
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.04      Germ cell neoplasms site unspecified NEC
16.16.04.001      Choriocarcinoma
Description A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). [MeSH]
MedDRA Code 10008757
MeSH ID D002822
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Choriocarcinoma | Choriocarcinoma (exc placental, ovarian & testicular) | Choriocarcinoma NOS | Choriocarcinomas
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00497Clomiphene--
BADD_D00498Clomiphene citrate--
The 1th Page    1    Total 1 Pages